1Frank RN. Etiologic mechanisms in diabetic retinopathy. In: Ryan SJ. Retina. 3rd Ed. St. Louis:Mosby Inc, 2001,1259-1294.
2Early Treatment Diabetic Retinopathy Study Research Group:Grading diabetic retinopathy from stereoscopic colour fundus photographs:an extention of the modified Airlie House classification:ETDRS Report NO 10. Ophthalmology, 1991,98 (Suppl): 786-806.
3Fukuda M. Clinical arrangement of classification of diabetic retinopathy. Tohoku J Exp Med, 1983, 141 Suppl:331-335.
4National Health and Medical Research Council. Clinical Practice Guidelines: Management of Diabetic Retinopathy. Canberra:NHMRC, 1997.
5Wilkinson CP, Ferris FL Ⅲ, Klein RE, et al. Proposed International clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology,2003, 110:1677-1682.
8Stitt AW, McGoldrick C, Rice-McCaldin A, et al. Impaired retinal angiogenesis in diabetes: role of advanced glycation end products and galectin-3. Diabetes, 2005,54:785-794.
10Early Treatment Diabetic Retinopathy Study Research Group. Early photocoagulation for diabetic retinopathy. ETDRS report number9. Ophthamology,1991, 98:766-785.
二级参考文献7
1Tso MOM. Retinal photocoagulation therapy[M] : Clinical application and biological basis of therapeutic effects. In:Tso MOM, ed. Retinal Disease. Philadelphia. J B Lippincott Company, 1998,247-262.
2Blankenship GW. A clinical comparison of central and peripheral argon laser panretinal photocoagulation for proliferative diabetic retinopathy[ J ]. Ophthalmology, 1998,95.170-177.
3Brown GC, Brown MM, Cater JR. Retinal capillary nonperfusion and diabetic retinopathy[ J ]. Ann Ophthalmol,1998,30: 383-387.
